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Abstract
Background: Adult attention deficit hyperactivity disorder (ADHD) shows a robust association with alcohol and
cannabis misuse, and these relationships are expressed differently in males and females. Manifestation of specific
ADHD symptom profiles, even in the absence of the full disorder, may also be related to problems with alcohol and
cannabis, although these relationships have not been investigated in epidemiological studies. To address this question,
we studied the sex-specific associations of ADHD symptomatology with problematic alcohol and cannabis use in a
representative sample of adults aged 18 years and older residing in Ontario, Canada.
Methods: Data were obtained from the Centre for Addiction and Mental Health Monitor, an ongoing cross-sectional
telephone survey, between January 2011 and December 2013. Respondents (n = 5080) reported on current ADHD
symptomatology, measured using the Adult ADHD Self-Report Version 1.1 Screener (ASRS-V1.1) and four additional items,
and alcohol and cannabis use, which were measured using the Alcohol Use Disorders Identification Test (AUDIT) and the
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), respectively. Logistic regression analyses were
conducted in men and women to test the association of each ADHD symptom cluster (hyperactivity, inattentiveness,
impulsivity) with problematic alcohol and cannabis use.
Results: After controlling for age, education, and comorbid internalizing and externalizing psychopathology, hyperactive
symptoms were associated with problematic alcohol use in both men and women and with problematic cannabis use in
men. Impulsive symptoms were independently associated with problematic cannabis use in men. By contrast, inattentive
symptomatology predicted problems with alcohol and cannabis only in women. In all models, age was negatively
associated with substance misuse and externalizing behavior was positively correlated and the strongest predictor of
hazardous alcohol and cannabis use.
Conclusions: ADHD symptom expression in adulthood is related to concurrent hazardous use of alcohol and cannabis.
Distinctive ADHD symptom profiles may confer increased risk for substance misuse in a sex-specific manner.
* Correspondence: nathan.kolla@mail.utoronto.ca
1Centre for Addiction and Mental Health, Toronto, ON, Canada
2Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Full list of author information is available at the end of the article
© 2016 Kolla et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kolla et al. BMC Psychiatry  (2016) 16:50 
DOI 10.1186/s12888-016-0746-4
Kolla et al. BMC Psychiatry  (2016) 16:50 Page 2 of 9Background
More individuals receive treatment for problematic alco-
hol and cannabis use than any other substance of abuse
[1]. Links between alcohol or cannabis misuse and atten-
tion deficit hyperactivity disorder (ADHD), a neurodeve-
lopmental illness comprising symptoms of inattention,
hyperactivity, and impulsivity, have been identified in
adults [2, 3]. Some reports have additionally detected rela-
tionships between ADHD symptom burden in adulthood
and severity of substance misuse [4], suggesting that
certain ADHD symptom profiles may influence expression
of problematic alcohol and cannabis use in ADHD.
By contrast, only a handful of studies have tested the
association of ADHD symptom domains with substance
use measures in non-clinical samples of adults. This re-
search is a vital line of inquiry, since subthreshold ADHD
phenotypes are likely more common than the clinical dis-
order and may also be associated with hazardous alcohol
or cannabis use. Two studies that investigated samples of
non-treatment seeking college students reported relation-
ships between ADHD symptom clusters and substance
use outcomes. One found a positive association of inatten-
tive symptoms with alcohol use and cannabis misuse that
was independent of comorbid internalizing and exter-
nalizing psychopathology [5], while the other linked in-
attentive and hyperactive symptoms to greater cannabis
use after controlling for conduct disorder and antisocial
personality disorder [6]. While these studies describe
an important connection between ADHD symptom do-
mains and potentially hazardous substance use, results
were likely influenced by self-selection bias and sampling
of higher functioning populations [5, 6].
Epidemiologic study designs can improve upon these
methodological limitations by providing estimates of key
associations at a population level. To the best of our
knowledge, only one cross-sectional, population-based
study has analyzed ADHD symptom domains in relation
to substance use outcomes [7]. After controlling for life-
time history of major depressive disorder, anxiety disorders,
and conduct disorder, hyperactive-impulsive symptoms
present by age 17 years in an adult population sample were
associated with increased risk of lifetime alcohol and can-
nabis use disorder. Inattentive symptoms additionally pre-
dicted lifetime history of cannabis use disorder [7]. These
results provide initial epidemiological evidence of a link
between dimensional ADHD measures and substance
misuse but do not answer the critical question of
whether active ADHD symptomatology in adulthood pre-
dicts contemporaneous problems with alcohol or cannabis.
Another important gap in the literature relates to the
paucity of information on potential sex differences
associated with ADHD symptom expression and sub-
stance misuse. Most population studies that examined
ADHD diagnosis or symptomatology and substance usemeasures controlled for sex in the adjusted analyses and
did not report on any sex-specific relationships [7–10].
Understanding how sex may influence these relation-
ships has clinical relevance, since recent evidence indi-
cates that risk for alcohol and substance use disorders in
ADHD may be greater in women [11]. However, it is
presently unknown whether ADHD symptoms and sub-
stance misuse manifest differently in men and women at
a population level. Hence, there is a pressing need for
robust epidemiological data to better understand the
manifestation of ADHD symptom cluster expression by
substance use outcomes and sex. The objective of the
present study was to investigate the association of active
ADHD symptom domain expression with problematic
alcohol and/or cannabis use by sex in a population-based,
representative study of Canadian adults. We hypothesized
that ADHD symptom expression would predict prob-
lematic substance misuse in both men and women even
after controlling for age, education, internalizing symp-
toms, and externalizing symptoms and that these rela-
tionships would be expressed differentially by sex.
Methods
Participants and procedures
Telephone interviews were conducted over 36 months
between January 2011 and December 2013 in a similar
manner as previously reported [12]. Informed consent
was obtained from the participants at the start of the
telephone survey. Data were acquired from the Centre
for Addiction and Mental Health (CAMH) Monitor, a
cross-sectional, computer-assisted telephone survey
(landlines and cellphones) of Ontario residents (18 years
and older) conducted by CAMH, Toronto, Ontario, and
administered by the Institute for Social Research at
York University, Toronto, Ontario. For details, see [13].
Each monthly cycle of the survey utilized a two-stage
probability sampling procedure. In the first stage, a ran-
dom sample of telephone numbers was selected with
equal probability from each regional stratum. In the
second stage, one respondent from each household was
selected based on the following criteria: 1) age 18 years
or older; 2) most recent birthday from the date of the
telephone interview; and 3) ability to complete the
interview in English. Response rates based on estimated
eligibility of the sample averaged 50 %. No information
was available for the non-participants. All study com-
ponents were approved by the Research Ethics Boards
of CAMH, York University, and the University of Western
Ontario in London, Ontario.
Results used in the analyses were based on “valid”
responses to survey questions. That is, responses such
as “don’t know” or refusals were treated as missing data
and excluded from analyses. Overall, 994 individuals were
excluded from the analyses due to missing data. The final
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measures. Altogether, there were 2066 males (40.7 %) and
3014 females (59.3 %). Participant ages ranged from 18 to
97 years with a mean age of 54.4 ± 16.5 years. Regarding
education, 31.8 % completed high school or less, 36.6 %
completed some or all requirements for community col-
lege or a technical diploma, and 31.6 % completed some
or all requirements for a Bachelor’s degree or higher.
Measures
Adult ADHD Self-Report Version 1.1 Screener (ASRS-V1.1)
The ASRS-V1.1 [14] is derived from symptoms of
ADHD as identified in the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV;
[15]). Among the 18 DSM-IV symptoms of ADHD, 6
were found to be predictive of ADHD as determined by
clinical assessment, and these items comprise the ASRS-
V1.1. Four of the items relate to symptoms of inattention
and two index hyperactivity symptoms. The ASRS-V1.1
was selected over the full version of the ASRS, because we
required parsimony given the length of the telephone
survey. Moreover, the ASRS-V1.1 is more sensitive and
specific and offers better classification accuracy than the
ASRS [14, 16, 17]. For the present study, three additional
questions tapping impulsivity symptoms of ADHD (e.g.,
finishing others’ sentences, difficulty waiting turn, and
interrupting others) outlined in the most recent edition of
the DSM (DSM-5 [18]) were included to provide an index
of impulsivity. An additional item relating to hyperactivity
(e.g., difficulty remaining seated) was included to provide
an equal number of impulsive and hyperactivity symp-
toms. These items were drawn from the full version of the
ASRS. Participants were required to rate each item using
a 5-point, Likert-type scale with higher scores indicative of
more severe symptoms. We selected these items, because
a previous factor analysis [19] showed the presence of a
general factor within an adult sample that used these same
10 items from the ASRS as an ADHD screener. Further-
more, a three-factor model that separated impulsivity and
hyperactivity was found to summarize the data better than
a combined hyperactivity/impulsivity factor.
The standardized Cronbach’s alpha for the full 10-item
scale was 0.80, indicating good internal consistency [20].
The Cronbach’s alpha coefficients for the inattention,
impulsivity, and hyperactivity subscales were 0.77, 0.62,
and 0.54, respectively. The lower internal consistency
of the inattention and impulsivity subscales was not
unexpected given that the subscales comprised four
and three items, respectively.
Alcohol Use Disorders Identification Test (AUDIT)
The AUDIT is an extensively validated 10-item, Likert-type
screening instrument that was developed by the World
Health Organization (WHO) and designed to identifyindividuals presenting less severe alcohol problems [21, 22].
A score of eight or greater on the AUDIT is indicative of
hazardous alcohol use. The use of a cut-off score of 8+ as a
positive screen for both males and females has been used in
Ontario and Canadian national surveys [23, 24].
Alcohol, Smoking and Substance Involvement Screening
Test (ASSIST)
The cannabis subscale of the ASSIST is a 6-item
screening instrument that assesses risk of experiencing
health, financial, legal, social, and relationship problems
associated with cannabis use [25]. A score of four or
more is indicative of moderate or high risk of problematic
use [26]. The ASSIST cannabis subscale showed overall
good test-retest reliability in the original study.
General Health Questionnaire (GHQ12)
The GHQ12 is a 12-item screening instrument that
captures current symptoms of depression, anxiety, and
social functioning [27]. Items are rated on a 4-point,
Likert-type scale. Higher scores reflect greater psycho-
logical distress, and a score of 3 or greater denotes a
positive screen. The GHQ12 was developed for use in
adult, non-clinical populations and demonstrates strong
psychometric properties [28].
Conduct disorder symptoms
The Antisocial Personality Disorder Scale from the Mini-
International Neuropsychiatric Interview (MINI-APD) is a
12-item, dichotomous scale that assesses delinquent
behavior and provided a measure of externalizing psy-
chopathology [29]. One item was excluded from the
MINI-APD (forced someone to have sex before age
15 years) as required by our institutional review board.
Externalizing psychopathology for the current study
was defined as one or more delinquent behaviors present
before age 15 years.
Demographic variables
Since increasing age relates to a decline in ADHD symp-
toms [30] and lower socioeconomic status has been
linked to an ADHD diagnosis [31], we included age and
education in the analyses.
Statistical analysis
For each of the variables included in the analyses, com-
parisons were made between men and women in the
sample. Continuous variables were compared using in-
dependent sample t-tests or the Mann-Whitney U test
for those variables not following a normal distribution.
Dichotomous variables were compared using chi-square
tests. A series of logistic regressions were then applied
to estimate the associations of problematic alcohol or
cannabis use with ADHD symptom domains. Logistic
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testing the relationship between ADHD symptom severity
and alcohol and/or cannabis misuse as categorical out-
comes. Forced entry logistic regression was employed,
given that the models were theoretically-driven and there
were relatively few predictor variables. For each dependent
variable (problematic alcohol use or problematic cannabis
use), three separate models were constructed, one for each
ADHD symptom cluster (hyperactive, impulsive, and in-
attentive symptoms) indexed by the ASRS-V1.1 screener
and supplementary items. We considered entering inatten-
tion and hyperactivity/impulsivity symptom domains sim-
ultaneously in the regression analyses; however, we were
interested in understanding the separate contributions of
inattention, hyperactivity, and impulsivity symptom profiles
in the current study. The specific inattention and hyper-
activity/impulsivity factors, after the common variance was
accounted for by a general factor model, have been inter-
preted as residual and unclear for interpretation [19]. Thus,
we opted to enter the domains of inattention, hyperactivity,
and impulsivity as separate predictors in each regression
analysis. To achieve our study objective and determine
whether differences emerged between sexes, each regres-
sion model was run separately for men and women. Odds
ratios with 95 % confidence intervals were generated from
these regression analyses. Comparisons between models
were made using the Akaike Information Criterion (AIC).
The variance inflation factor (VIF) was examined for each
model to inspect for high inter-correlations among inde-
pendent variables. The VIF was less than 1.3 for each
model, suggesting that estimates were not significantly af-
fected by collinearity [32]. All analyses were completed
using the R project for statistical computing [33].Table 1 Demographic and clinical variables
Women
Demographics
Agea 54.0 ± 16.1
Postsecondary educationb 69.0
ADHD Symptomatology
Inattentiona 3.1 ± 2.9
Hyperactivitya 2.1 ± 2.2






Conduct disorder symptomsb 15.7
ASSIST Alcohol, Smoking and Substance Involving Screening Test, AUDIT Alcohol Us
avalue expressed as mean ± standard deviation; bvalue expressed as percentage; ct-Results
Sample characteristics
Comparisons between men and women on demographic
variables, measures of internalizing and externalizing
psychopathology, substance misuse, and ADHD symp-
tom cluster scores are presented in Table 1. The two
groups were similar in age and education level. Men en-
dorsed more externalizing psychopathology and less psy-
chological distress than women. Women reported greater
active inattentive and impulsive symptomatology, whereas
males reported higher rates of problematic alcohol and
cannabis use.
Regression analyses
As depicted in Table 2, problematic drinking was related
to differential expression of ADHD symptom domains
by sex. For both sexes, hyperactive symptoms were posi-
tively associated with problematic alcohol use and im-
pulsive symptomatology also predicted alcohol misuse in
men. In women, but not men, severity of inattentive symp-
toms additionally predicted problematic alcohol use. In all
models, externalizing psychopathology emerged as the
strongest predictor of alcohol misuse. Age was also nega-
tively correlated with problematic alcohol use in all models.
No relationship was detected between active internalizing
symptoms and problematic drinking, controlling for age,
education, externalizing psychopathology, and ADHD
symptom domains.
Table 3 highlights the relationship between ADHD
symptom clusters and problematic cannabis use in
men and women. Results revealed that only inattentive
symptoms predicted problematic cannabis use in
women, whereas hyperactive and impulsive symptoms,Men Test statistic p value
53.4 ± 16.2 −1.24c 0.223
67.2 1.82d 0.157
2.8 ± 2.7 3.68e 0.000
2.1 ± 2.2 0.64e 0.534





e Disorders Identification Test, GHQ-12 General Health Questionnaire
test; dchi-square; eMann-Whitney U
Table 2 Logistic regression for positive AUDIT screen divided by sex
Women Men
Odds ratio Critical intervals p value Odds ratio Critical intervals p value
Model 1
Intercept 0.292 0.160–0.525 0.000 0.545 0.361–0.820 0.004
Hyperactivity 1.132 1.063–1.205 0.000 1.073 1.023–1.124 0.003
Age 0.961 0.951–0.971 0.000 0.971 0.965–0.978 0.000
Conduct Disorder Symptoms 1.621 1.120–2.312 0.009 1.664 1.330–2.079 0.000
Postsecondary Education 0.882 0.625–1.261 0.480 1.217 0.970–1.535 0.093
Psychological Distress 1.038 0.698–1.513 0.851 1.092 0.806–1.465 0.564
Akaike Information Criterion 1254.9 2224.5
Model 2
Intercept 0.402 0.228–0.697 0.001 0.678 0.466–0.982 0.041
Inattention 1.060 1.007–1.115 0.025 1.029 0.992–1.068 0.128
Age 0.958 0.948–0.968 0.000 0.969 0.962–0.975 0.000
Conduct Disorder Symptoms 1.632 1.125–2.333 0.008 1.745 1.400–2.172 0.000
Postsecondary Education 0.814 0.578–1.161 0.245 1.166 0.931–1.468 0.185
Psychological Distress 1.050 0.699–1.550 0.808 1.099 0.804–1.489 0.550
Akaike Information Criterion 1264.3 2231.0
Model 3
Intercept 0.456 0.257–0.800 0.007 0.600 0.413–0.867 0.007
Impulsivity 1.021 0.953–1.091 0.555 1.091 1.039–1.145 0.000
Age 0.957 0.947–0.967 0.000 0.969 0.962–0.975 0.000
Conduct Disorder Symptoms 1.707 1.179–2.436 0.004 1.652 1.321–2.062 0.000
Postsecondary Education 0.833 0.593–1.188 0.303 1.151 0.918–1.451 0.227
Psychological Distress 1.196 0.810–1.731 0.355 1.093 0.808–1.466 0.556
Akaike Information Criterion 1269.5 2221.5
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misuse in men. Similar to the regressions that tested prob-
lematic alcohol use as the dependent variable, age and ex-
ternalizing psychopathology were negatively and positively
associated with problematic cannabis use, respectively.
Externalizing psychopathology was the strongest predictor
of cannabis misuse in all models. However, in contrast to
the previous regression models, current internalizing
psychopathology predicted problematic cannabis use,
controlling for ADHD symptom domains, externalizing
psychopathology, and demographic variables in five of
the six analyses.
Discussion
As far as we are aware, this is the first population-
based study of adults to examine the association of
active hyperactive, impulsive, and inattentive symptom-
atology with problematic alcohol and cannabis use.
Accumulating evidence from genetic studies suggests
that conceptualization of ADHD symptomatology as a
continuum of quantitative traits may be preferable tocategorical approaches [34]. Accordingly, the use of di-
mensional measures that reflected active ADHD symp-
tom burden and instruments that captured current
substance use problems and psychiatric symptoms
allowed us to draw inferences about how adult expres-
sion of ADHD symptom profiles may relate to concur-
rent problems with alcohol or cannabis. We detected
modest associations between ADHD symptom clusters
and substance misuse that were expressed differently by
sex. In keeping with proposals advocating for symptom-
based approaches to researching psychiatric illness [35],
these results highlight the clinical importance of ADHD
symptom expression in predicting problematic sub-
stance use and suggest that interventions targeting sub-
stance misuse in ADHD could also be directed toward
subclinical ADHD phenotypes associated with specific
symptom profiles.
Our results reveal that hyperactive, impulsive, and con-
duct disorder symptoms all predicted problematic alcohol
and cannabis use in males, which agrees with previous
research linking markers of behavioral disinhibition to
Table 3 Logistic regression for positive ASSIST screen divided by sex
Women Men
Odds ratio Critical intervals p value Odds ratio Critical intervals p value
Model 1
Intercept 0.208 0.091–0.463 0.000 0.494 0.276–0.878 0.017
Hyperactivity 1.060 0.976–1.148 0.162 1.083 1.014–1.156 0.017
Age 0.938 0.922–0.953 0.000 0.952 0.941–0.963 0.000
Conduct Disorder Symptoms 4.024 2.642–6.101 0.000 2.594 1.894–3.553 0.000
Postsecondary Education 1.327 0.818–2.236 0.269 0.525 0.384–0.719 0.000
Psychological Distress 1.938 1.232–3.007 0.004 1.663 1.120–2.434 0.010
Akaike Information Criterion 785.7 1116.3
Model 2
Intercept 0.185 0.084–0.392 0.000 0.727 0.435–1.207 0.220
Inattention 1.129 1.060–1.203 0.000 1.002 0.950–1.055 0.937
Age 0.936 0.920–0.951 0.000 0.948 0.938–0.959 0.000
Conduct Disorder Symptoms 3.583 2.328–5.484 0.000 2.768 2.031–3.775 0.000
Postsecondary Education 1.213 0.748–2.039 0.448 0.499 0.366–0.682 0.000
Psychological Distress 1.538 0.956–2.435 0.070 1.819 1.204–2.712 0.004
Akaike Information Criterion 777.3 1120.2
Model 3
Intercept 0.230 0.104–0.491 0.000 0.599 0.357–0.999 0.051
Impulsivity 1.052 0.966–1.142 0.234 1.076 1.003–1.153 0.040
Age 0.936 0.920–0.951 0.000 0.949 0.939–0.959 0.000
Conduct Disorder Symptoms 3.974 2.600–6.046 0.000 2.617 1.911–3.583 0.000
Postsecondary Education 1.260 0.780–2.112 0.361 0.494 0.362–0.675 0.000
Psychological Distress 1.980 1.262–3.062 0.002 1.707 1.151–2.493 0.007
Akaike Information Criterion 785.1 1121.3
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composed mainly of men [36, 37]. Taken together, these
findings accord well with a model that organizes antisocial
behaviors, substance misuse, and impulsive traits along a
spectrum of externalizing psychopathology [38], for which
there is growing evidence of a common genetic liability
[39]. Since dimensional measures of high ADHD symp-
tomatology show significant heritability [40], one explan-
ation for these findings is that a constellation of early
externalizing behaviors and high adult hyperactive/impul-
sive symptom burden may represent an intermediate
phenotype of adult problematic substance use. Support
for this hypothesis comes from twin research reporting a
shared genetic influence of adolescent hyperactive/impul-
sive ADHD and conduct disorder on alcohol dependence
in adult males [41]. Population-based investigations that
examined the genetic mechanisms of high impulsive and
hyperactive symptomatology in adults with hazardous
substance use could advance our understanding of po-
tential subclinical ADHD phenotypes linked to adverse
health outcomes.Among the three ADHD symptom clusters, hyperactivity
showed the strongest relationship with problematic alcohol
use in females. This result is broadly consistent with results
from a longitudinal design that detected a relationship
between hyperactive symptoms assessed during child-
hood and indicators of alcohol misuse among adult
females [42]. Additional study results from the present
investigation highlight a sex-specific association of in-
attentive symptomatology with alcohol and cannabis
misuse that was present only in females. Prior research
connects inattentive ADHD symptomatology to cannabis
and alcohol misuse [5, 43, 44], and one interpretation of
our findings is that in general adult populations, the
ADHD symptom domain of inattentiveness is more rele-
vant to expression of risky alcohol and cannabis use in
females compared with males. Since inattentive symptoms
in ADHD exhibit a dose-dependent relationship with
several forms of neurocognitive impairment [45] and are
associated with poorer occupational functioning [46],
manifestation of high inattentive symptomatology may re-
late to several markers of vulnerability that increase overall
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ations could be mediated by common genetic underpin-
nings. For example, a genetic variant of the dopamine
transporter gene, a molecular target of interest in ADHD,
was found in one study to be more common in women
with high inattentive symptoms [47], and this same geno-
type has also been linked to structural and functional brain
changes in cannabis use disorders [48] and processing of
alcohol cues [49].
It is notable that externalizing psychopathology emerged
as the strongest predictor of alcohol and cannabis misuse
in every model tested, although relationships between
ADHD symptomatology and substance misuse still per-
sisted after controlling for conduct disorder symptoms.
The associations between externalizing psychopathology
and hazardous cannabis use were particularly robust.
There is some debate in the literature as to whether asso-
ciations between ADHD and substance misuse are medi-
ated exclusively by conduct-disordered behaviors. For
example, one longitudinal study of a non-clinical sample
examined childhood behaviors in relation to adult sub-
stance use disorders and reported that oppositional but
not ADHD symptom clusters predicted cannabis use dis-
orders in adulthood [50]. By contrast, other studies have
found that both ADHD and externalizing behaviors
assessed in adulthood predict cannabis misuse [5]. Dis-
crepant results likely relate to the variable developmental
contexts in which ADHD symptoms were measured [5]
and differences in sample characteristics and operatio-
nalization of externalizing psychopathology.
An important clinical implication of our study is the
potential for enhanced detection of problematic alcohol
and/or cannabis use through identification of high ADHD
symptom expression. Several reasons point to a growing
awareness of adult ADHD in the general public [51], and
front line clinicians will likely come in contact with in-
creasing numbers of patients, including parents of chil-
dren with ADHD, who query the disorder in themselves.
Many of these individuals will not meet diagnostic criteria
for ADHD but may still endorse high levels of ADHD
symptomatology associated with problematic health be-
haviors. Since patients typically under-report or do not
disclose their substance use [52], screening for hazardous
drug or alcohol use in younger adult age groups who
present subthreshold ADHD could represent a relatively
simple and efficient means of identifying a subset of indi-
viduals at high risk for substance misuse. Furthermore,
given evidence that treatment of ADHD may lead to a re-
duction in substance use [53], our results provide incen-
tive for the development of age-appropriate interventions
that could potentially address problematic substance use
in specific subthreshold ADHD profiles.
We note several limitations of the present investiga-
tion common to most epidemiological surveys. First,given the cross-sectional study design, we are unable to
make inferences about the direction of the relationship
between ADHD symptom expression and problematic
substance use. On the other hand, longitudinal studies
have generally found that childhood ADHD predicts de-
velopment of alcohol and cannabis use disorders in
adulthood [54], suggesting a similar temporal ordering
of high ADHD symptom expression and problematic
substance use. Second, data were self-reported and did
not include verification from informants that is typically
required to make a clinical diagnosis of ADHD. How-
ever, since the purpose of the study was to assess ADHD
symptomatology, as opposed to the clinical disorder, and
strong agreement has been demonstrated between self-
and observer-reported severity of adult ADHD symp-
toms [55], this aspect of the study design offered an
efficient strategy to address our main research ques-
tions. Third, although our response rate of over 50 %
compares favorably with other telephone surveys, and
data were weighted to reflect a representative sample of
adults from the third to tenth decades of life, it is still
possible that sampling bias was present. As the partici-
pant age range was quite broad, it is also possible that
the observed associations were not representative of all
age groups, given that age was a significant predictor
for each model. Fourth, our results may have been af-
fected by response bias, as some evidence suggests that
subjects may under-report or provide more favorable in-
formation about their alcohol and substance use when
data are obtained from telephone interviews compared
with anonymous surveys [56, 57]. Finally, the possibility of
selection bias in our study cannot be overlooked, espe-
cially since some reports indicate that individuals with
more severe ADHD and alcohol use disorders may be less
likely to participate in studies [58, 59], although other
research has found that markers of cannabis use severity
do not influence study participation [60].Conclusions
In summary, our findings highlight a previously unre-
ported nexus between active ADHD symptom cluster
expression and problematic alcohol and/or cannabis use
in a general adult population. These observations are of
interest clinically, because they show that specific ADHD
symptom profiles, even without evidence of the clinical
disorder, are still associated with adverse health outcomes.
Associations between ADHD symptom expression and
hazardous substance use manifested differently in males
and females, suggesting that sex effects are critical to
understanding these relationships. Our results merit
further study of subthreshold ADHD phenotypes to
determine whether clinical intervention leads to improved
health outcomes.
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